BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 1337911)

  • 1. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
    Dzau VJ
    Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ACE inhibition on myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue renin-angiotensin system in myocardial hypertrophy and failure.
    Dzau VJ
    Arch Intern Med; 1993 Apr; 153(8):937-42. PubMed ID: 8386920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition: prospects for the future.
    Jackson B; Mendelsohn FA; Johnston CI
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S4-8. PubMed ID: 1725200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The renin-angiotensin system: systemic and local function].
    Gohlke P; Ganten D; Lang RE; Unger T
    Z Kardiol; 1988; 77 Suppl 3():1-12. PubMed ID: 2850684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
    Gensini GF; Lippi D; Conti AA
    Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tissue renin-angiotensin system and its functional role.
    Johnston CI; Burrell LM; Perich R; Jandeleit K; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():1-5. PubMed ID: 1327595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
    Hanif K; Bid HK; Konwar R
    Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects on angiotensin-converting enzyme: from gene to disease.
    Baudin B
    Clin Chem Lab Med; 2002 Mar; 40(3):256-65. PubMed ID: 12005216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.